Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Crinetics Pharmaceuticals, Inc.](/topic/$crnx)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$crnx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$crnx/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -X%  
**1 Month**: XX% +12%  
**6 Months**: XX% +36%  
**1 Year**: XX% -XX%  
**1-Year High**: XXX% on 2024-10-20  
**1-Year Low**: XX% on 2025-05-07  

**Most Supportive Themes**
- **Positive Analyst Ratings and Biotech Momentum:** (35%) Posts highlight positive analyst ratings and the strong performance of biotech stocks, including CRNX.
- **FDA Approval and Product Launch:** (25%) News of FDA approval for Palsonify, Crinetics' first approved product, is generating positive sentiment.
- **Stock Performance and Technical Analysis:** (20%) Posts discuss CRNX's strong performance, with mentions of significant gains and positive trends.
  
**Most Critical Themes**
- **Competition and Market Challenges:** (5%)  Mentions of competition from established drugs suggest potential challenges for CRNX.
- **General Market Volatility:** (5%)  Some posts mention market volatility and the broader economic context, which could impact CRNX.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXX     | XX% | XX       | X% |
| TikTok  | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | XX       | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Crinetics Pharmaceuticals, Inc.

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -X%
1 Month: XX% +12%
6 Months: XX% +36%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-10-20
1-Year Low: XX% on 2025-05-07

Most Supportive Themes

  • Positive Analyst Ratings and Biotech Momentum: (35%) Posts highlight positive analyst ratings and the strong performance of biotech stocks, including CRNX.
  • FDA Approval and Product Launch: (25%) News of FDA approval for Palsonify, Crinetics' first approved product, is generating positive sentiment.
  • Stock Performance and Technical Analysis: (20%) Posts discuss CRNX's strong performance, with mentions of significant gains and positive trends.

Most Critical Themes

  • Competition and Market Challenges: (5%) Mentions of competition from established drugs suggest potential challenges for CRNX.
  • General Market Volatility: (5%) Some posts mention market volatility and the broader economic context, which could impact CRNX.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXX XX% XXX XX% XX X%
TikTok X X% X X% X X%
Total XXX XX% XXX XX% XX X%
Crinetics Pharmaceuticals, Inc. (CRNX) Sentiment
/topic/$crnx/sentiment